entertainment -WSS

entertainment

author：explore 2025-09-08 08:54:28 - browse：5937

Travere Therapeutics said Thursday that a study meant to confirm the benefit of its newly approved drug for a rare kidney disorder narrowly failed.

In the trial, 404 patients with the disorder, IgA nephropathy, were randomized to receive either Travere’s daily pill, Filspari, or irbesartan, a decades-old blood pressure drug often used to help manage the disease. Early data had showed the drug cut protein levels in the urine, a biomarker of kidney function, by half after nine months. That convinced regulators to give Filspari accelerated approval in February, pending full results using a more direct measure of kidney function.

The new data, after 24 months, showed that patients who received Filspari declined less quickly than those in the control group. But the results just missed statistical significance, with a P value of 0.058.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： At least 12 people were injured in a blast at a port in northwest Turkey

hotspot

WSS

ACA's risk program benefits Blue Cross Blue Shield insurers

Wisconsin governor employs partial veto to fund schools for 4 centuries

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

Appeals court upholds Josh Duggar's conviction for downloading child sex abuse images

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

leisure time

entertainment

entertainment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

Supreme Court strikes down use of affirmative action

NYC plans to house migrants on an island in the East River

BioMarin wins approval for gene therapy to treat hemophilia A

Medicare wants to send $9 billion to 340B hospitals

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

Duchenne breakthrough therapy leaves behind pioneering families

The U.S. needs a new definition of substance use “recovery”

focus

Create a giant ice tray with this foil pan hack to keep food cold this summer

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

Eisai exec who led development of Alzheimer’s drug to retire

Wisconsin governor employs partial veto to fund schools for 4 centuries

Illinois to ban advertising for guns allegedly marketed to kids and militants

Recent heat wave in the Mediterranean caused by climate change: Study

hotspot

focus

explore

focus